Il carcinoma mammario con differenziazione neuroendocrina. Osservazione clinica e revisione della letteratura
R. Saldamarco 1, A. Pulcini 1, G. Fabrizio 1, K. Fazzi 1, D. Feroci 1, R. Gabatel 1, G. Guerriero 1, C. Mercurio 1, D. Zimatore 1, L. Giacomelli 1
Affiliation
Article Info
1 Università degli Studi di Roma “La Sapienza”, Cattedra di Chirurgia Generale III
Abstract
Female breast carcinoma with neuroendocrine differentiation is a lesion which can enhance of conventional therapy added with tamoxifene-octreotide association. The Authors report a case completely responsive after two years therapy, which grading was: pT4, N1biii, Mx, G2 staging III.
Keywords
- Breast carcinomas
- neuroendocrine differentiation
- octreotide
- tamoxifene